Cargando…
Tumor M2-PK: A novel urine marker of bladder cancer
PURPOSE: Bladder cancer is a “Warburg-like” tumor characterized by a reliance on aerobic glycolysis and expression of pyruvate kinase M2 (PKM2). PKM2 oscillates between an active tetramer and an inactive dimer. We aim to further characterize PKM2, in particular PKM2 dimer, as a urinary biomarker of...
Autores principales: | Liu, Weiya, Woolbright, Benjamin L., Pirani, Karim, Didde, Ryan, Abbott, Erika, Kaushik, Gaurav, Martin, Paige, Hamilton-Reeves, Jill, Taylor, John A., Holzbeierlein, Jeffrey M., Anant, Shrikant, Lee, Eugene K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597081/ https://www.ncbi.nlm.nih.gov/pubmed/31246990 http://dx.doi.org/10.1371/journal.pone.0218737 |
Ejemplares similares
-
Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer
por: Woolbright, Benjamin L., et al.
Publicado: (2023) -
Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
por: Smelser, Woodson Wade, et al.
Publicado: (2017) -
Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
por: Rajendran, Ganeshkumar, et al.
Publicado: (2021) -
Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007) -
Optimizing Nutritional Status in Patients Undergoing Radical Cystectomy: A Systematic Scoping Review
por: Alam, Syed M., et al.
Publicado: (2021)